Related content

A phase II/III study comparing intravenous ZD9331 with gemcitabine in patients with pancreatic cancer

By Smith D.   Gallagher N.  

European Journal of Cancer, Vol. 39, Iss. 10, 2003-07 ,pp. : 1377-1383

Elsevier

Access to resources Recommend Favorite

A phase II trial of ZD0473 in platinum-pretreated ovarian cancer

By Gore M.E.   Atkinson R.J.   Thomas H.   Cure H.   Rischin D.   Beale P.   Bougnoux P.   Dirix L.   Smit W.M.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2416-2420

Elsevier

Access to resources Recommend Favorite

Phase I Study with a Weekly 1 h Infusion of Paclitaxel in Heavily Pretreated Patients with Metastatic Breast and Ovarian Cancer

By Klaassen U.   Wilke H.   Strumberg D.   Eberhardt W.   Korn M.   Seeber S.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 547-549

Elsevier

Access to resources Recommend Favorite

The Costs and Efficacy of Liposomal Doxorubicin in Platinum-Refractory Ovarian Cancer in Heavily Pretreated Patients

By Hensley M.L.   Hoppe B.   Leon L.   Sabbatini P.   Aghajanian C.   Chi D.   Spriggs D.R.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 464-469

Elsevier

Access to resources Recommend Favorite

Ifosfamide/Mesna as Salvage Therapy in Platinum Pretreated Ovarian Cancer Patients—Long-Term Results of a Phase II Study

By Baur Martina   Fazeny-Doerner B.   Hudec M.   Sevelda P.   Salzer H.   Dittrich Christian  

Cancer Investigation, Vol. 24, Iss. 1, 2006-03 ,pp. : 22-27

Informa Healthcare

Access to resources Recommend Favorite